Back to UBS Group AG UBS Group AG

IMDXIMDX
Showing 8 of 12 quarters

Position history for UBS Group AGUBS Group AG's holdings in INSIGHT MOLECULAR DIA INC

UBS Group AG holds 53,276 shares of IMDX (INSIGHT MOLECULAR DIA INC), worth $314,329 as of 2026-Q2. The position was increased (+134.2% shares).

Current Value

$314,329

Current Shares

53,276

Total Value Change

+$311,949

Total Shares Change

+52,441

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
53,276
+134.2%
$314,3290.0%$5.90
26
2026-Q1
Increased
22,751
+673.6%
$74,6240.0%$5.45
23
2025-Q4
Increased
2,941
+8.4%
$22,0580.0%$7.00
14
2025-Q3
Decreased
2,714
-82.3%
$9,0110.0%$3.23
0
2025-Q2
Increased
15,365
+478.9%
$46,4020.0%$3.20
22
2025-Q1
Decreased
2,654
-2.2%
$8,1210.0%$3.21
0
2024-Q4
Increased
2,714
+225.0%
$6,4600.0%$2.45
17
2024-Q3
Unchanged
835
0.0%
$2,3800.0%$2.88
0

Other major holders of IMDX: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used